Sonnet BioTherapeutics Holdings Management
Management criteria checks 2/4
Sonnet BioTherapeutics Holdings' CEO is Pankaj Mohan, appointed in Jan 2015, has a tenure of 9.5 years. total yearly compensation is $1.02M, comprised of 52.7% salary and 47.3% bonuses, including company stock and options. directly owns 2.01% of the company’s shares, worth $56.94K. The average tenure of the management team and the board of directors is 5.2 years and 4.8 years respectively.
Key information
Pankaj Mohan
Chief executive officer
US$1.0m
Total compensation
| CEO salary percentage | 52.7% |
| CEO tenure | 9.5yrs |
| CEO ownership | 2.0% |
| Management average tenure | 5.2yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Sonnet BioTherapeutics regains compliance with Nasdaq's minimum bid price requirement
Oct 04Sonnet BioTherapeutics announces 1-for-14 reverse stock split
Sep 16Sonnet gets clearance to start phase 1b/2a trial of SON-080 in Australia
Jul 22We're A Little Worried About Sonnet BioTherapeutics Holdings' (NASDAQ:SONN) Cash Burn Rate
Dec 19
Sonnet Bio issued U.S. patent for its albumin binding technology
Jun 08Sonnet shares rise after completing licensing agreement with New Life Therapeutics
May 03Sonnet BioTherapeutics reports FY results
Dec 17CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | -US$8m |
| Dec 31 2023 | n/a | n/a | -US$14m |
| Sep 30 2023 | US$1m | US$539k | -US$19m |
| Jun 30 2023 | n/a | n/a | -US$23m |
| Mar 31 2023 | n/a | n/a | -US$27m |
| Dec 31 2022 | n/a | n/a | -US$29m |
| Sep 30 2022 | US$1m | US$560k | -US$30m |
| Jun 30 2022 | n/a | n/a | -US$29m |
| Mar 31 2022 | n/a | n/a | -US$27m |
| Dec 31 2021 | n/a | n/a | -US$25m |
| Sep 30 2021 | US$792k | US$512k | -US$25m |
| Jun 30 2021 | n/a | n/a | -US$67m |
| Mar 31 2021 | n/a | n/a | -US$73m |
| Dec 31 2020 | n/a | n/a | -US$69m |
| Sep 30 2020 | US$2m | US$490k | -US$66m |
| Jun 30 2020 | n/a | n/a | -US$20m |
| Mar 31 2020 | n/a | n/a | -US$9m |
| Dec 31 2019 | n/a | n/a | -US$7m |
| Sep 30 2019 | US$548k | US$368k | -US$5m |
Compensation vs Market: Pankaj's total compensation ($USD1.02M) is above average for companies of similar size in the US market ($USD703.12K).
Compensation vs Earnings: Pankaj's compensation has increased whilst the company is unprofitable.
CEO
Pankaj Mohan (59 yo)
9.5yrs
Tenure
US$1,022,720
Compensation
Dr. Pankaj Mohan, Ph.D. founded Sonnet BioTherapeutics Holdings, Inc. in 2015 and has since served as a member of its Board of Directors. Dr. Mohan has been Chairman of Sonnet BioTherapeutics Holdings, Inc...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.5yrs | US$1.02m | 2.01% $ 56.9k | |
| Chief Scientific Officer & Co-Founder | 9.5yrs | US$626.41k | 0.059% $ 1.7k | |
| Chief Financial Officer | 5.2yrs | US$619.25k | 0.035% $ 989.0 | |
| Controller & Director | 5.5yrs | US$137.33k | 0.010% $ 293.1 | |
| Chief Technical Officer | 4.3yrs | no data | 0.049% $ 1.4k | |
| Chief Medical Officer | 3.3yrs | no data | 0.025% $ 716.3 | |
| Head of Clinical Operations | 3.3yrs | no data | no data |
5.2yrs
Average Tenure
67.5yo
Average Age
Experienced Management: SONN's management team is seasoned and experienced (5.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 9.5yrs | US$1.02m | 2.01% $ 56.9k | |
| Controller & Director | 9.3yrs | US$137.33k | 0.010% $ 293.1 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 1.8yrs | US$73.85k | 0% $ 0 | |
| Independent Director | 4.8yrs | US$59.35k | 0.037% $ 1.0k | |
| Independent Director | 6yrs | US$57.85k | 0.039% $ 1.1k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 4.7yrs | US$120.35k | 0.50% $ 14.3k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | 1.8yrs | no data | no data |
4.8yrs
Average Tenure
60yo
Average Age
Experienced Board: SONN's board of directors are considered experienced (4.8 years average tenure).